Browsing by Author Ngampiyaskul C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
1-Jan-2016A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based RegimensHomkham N.; Cressey T.; Ingsrisawang L.; Bouazza N.; Ngampiyaskul C.; Hongsiriwon S.; Srirojana S.; Kanjanavanit S.; Bhakeecheep S.; Coeur S.; Salvadori N.; Treluyer J.; Jourdain G.; Urien S.
5Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for NeonatesCressey T.; Punyawudho B.; Le Coeur S.; Jourdain G.; Saenjum C.; Capparelli E.; Jittayanun K.; Phanomcheong S.; Luvira A.; Borkird T.; Puangsombat A.; Aarons L.; Sukrakanchana P.; Urien S.; Lallemant M.; Sangsawang S.; Achalapong J.; Preedisripipat K.; Putiyanun C.; Wanchaitanawong V.; Yuthavisuthi P.; Ngampiyaskul C.; Kanjanavikai P.; Chotivanich N.; Hongsiriwon S.; Suwankornsakul W.; Sreshthatat P.; Kanjanasing A.; Kwanchaipanich R.; Rawangban B.; Santadusit S.; Jarupanich T.; Warachit B.; Siriwachirachai T.; Rojanakarin P.; Vivatpatanakul K.; Hanpinitsak S.; Wanasiri P.; Srirojana S.; Kongpanichkul R.; Bunjongpak S.; Sabsanong P.; Liampongsabuddhi P.; Pongdetudom K.; Khamja P.; Akarathum N.; Phonin S.; Limpitikul W.; Jungpipun J.; Petprakorp R.; Mahattanan S.; Kotchawet S.; Pilalai T.
2013Five-year trends in antiretroviral usage and drug costs in HIV-infected children in ThailandCollins I.; Cairns J.; Le Coeur S.; Pagdi K.; Ngampiyaskul C.; Layangool P.; Borkird T.; Na-Rajsima S.; Wanchaitanawong V.; Jourdain G.; Lallemant M.
2012High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited settingPuthanakit T.; Jourdain G.; Suntarattiwong P.; Chokephaibulkit K.; Siangphoe U.; Suwanlerk T.; Prasitsuebsai W.; Sirisanthana V.; Kosalaraksa P.; Petdachai W.; Hansudewechakul R.; Waranawat N.; Ananworanich J.; Bunupuradah T.; Phasomsap C.; Kaew-on P.; Kanjanavanit S.; Hinjiranandana T.; Layangool P.; Kamonpakorn N.; Buranabanjasatean S.; Ngampiyaskul C.; Chotpitayasunondh T.; Chanpradub S.; Leawsrisuk P.; Chearskul S.; Vanprapar N.; Phongsamart W.; Lapphra K.; Chearskul P.; Wittawatmongkol O.; Intalapaporn K.; Kongstan N.; Pannin N.; Maleesatharn A.; Khumcha B.; Aurpibul L.; Wongnum N.; Nadsasarn R.; Lumbiganon P.; Tharnprisan P.; Udompanich T.; Yentang M.; Khonponoi A.; Maneerat N.; Denjunta S.; WatanapornS.; Yodsuwan C.; Srisuk W.; Somsri S.; Surapanichadul K.
2Incidence of tuberculosis and associated mortality in a cohort of human immunodeficiency virus-infected children initiating antiretroviral therapySalvadori N.; Ngo-Giang-Huong N.; Duclercq C.; Kanjanavanit S.; Ngampiyaskul C.; Techakunakorn P.; Puangsombat A.; Figoni J.; Mary J.; Collins I.; Cressey T.; Coeur S.; Sirirungsi W.; Lallemant M.; McIntosh K.; Jourdain G.
2011Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenChokephaibulkit K.; Cressey T.R.; Capparelli E.; Sirisanthana V.; Muresan P.; Hongsiriwon S.; Ngampiyaskul C.; Limwongse C.; Wittawatmongkol O.; Aurpibul L.; Kabat B.; Toye M.; Smith M.E.; Eksaengsri A.; McIntosh K.; Yogev R.
2011Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenChokephaibulkit K.; Cressey T.R.; Capparelli E.; Sirisanthana V.; Muresan P.; Hongsiriwon S.; Ngampiyaskul C.; Limwongse C.; Wittawatmongkol O.; Aurpibul L.; Kabat B.; Toye M.; Smith M.E.; Eksaengsri A.; McIntosh K.; Yogev R.